Preexisting Lung Disease and Lung Cancer

Jul 5, 2016 by in ONCOLOGY Comments Off on Preexisting Lung Disease and Lung Cancer

Preexisting Lung Disease and Lung Cancer Keith M. Kerr Elsewhere in this book are reviews of the three preinvasive lung diseases that are recognized in the WHO classification of lung…

read more

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

Jul 5, 2016 by in ONCOLOGY Comments Off on Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia Keith M. Kerr Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is described in the WHO classification of lung tumors as a generalized proliferation of…

read more

Lung Cancer Stem Cells

Jul 5, 2016 by in ONCOLOGY Comments Off on Lung Cancer Stem Cells

Lung Cancer Stem Cells Timothy Craig Allen Although lung stem cells and the hypothesis of lung cancer stem cells do not fit the typical paradigm of preneoplastic and preinvasive lesions,…

read more

Atypical Adenomatous Hyperplasia

Jul 5, 2016 by in ONCOLOGY Comments Off on Atypical Adenomatous Hyperplasia

Atypical Adenomatous Hyperplasia Keith M. Kerr This chapter considers the current theories of adenocarcinogenesis in the human lung and the place that atypical adenomatous hyperplasia (AAH) has in this process….

read more

New Staging System for Lung Cancer

Jul 5, 2016 by in ONCOLOGY Comments Off on New Staging System for Lung Cancer

New Staging System for Lung Cancer Philip T. Cagle THE NEW TNM STAGING SYSTEM FOR LUNG CANCER As noted in the previous chapter, the TNM staging system for lung cancer,…

read more

Molecular Prognostic Markers of Lung Cancer

Jul 5, 2016 by in ONCOLOGY Comments Off on Molecular Prognostic Markers of Lung Cancer

Molecular Prognostic Markers of Lung Cancer Sanja Dacic Many studies have examined potentially prognostic genetic changes in lung carcinoma using different methodologies from immunohistochemistry to gene expression profiling. However, no…

read more

Molecular Targeted Therapy of Lung Cancer

Jul 5, 2016 by in ONCOLOGY Comments Off on Molecular Targeted Therapy of Lung Cancer

Molecular Targeted Therapy of Lung Cancer Sanja Dacic The most frequently targeted pathways in non-small cell lung carcinomas (NSCLC) have involved the epidermal growth factor receptor (EGFR), vascular endothelial growth…

read more

Molecular Diagnostics of Lung Cancer

Jul 5, 2016 by in ONCOLOGY Comments Off on Molecular Diagnostics of Lung Cancer

Molecular Diagnostics of Lung Cancer Sanja Dacic The diagnosis of lung carcinoma is largely based on morphology. Ancillary tools such as histochemical stains and immunohistochemistry are used in occasional cases….

read more
Get Clinical Tree app for offline access